Checkpoint Therapeutics’ (CKPT) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Checkpoint Therapeutics (NASDAQ:CKPT – Free Report) in a report published on Monday, Benzinga reports. They currently have a $20.00 price objective on the stock. Checkpoint Therapeutics Stock Performance Shares of NASDAQ:CKPT opened at $2.46 on Monday. Checkpoint Therapeutics has a 52 week low of $1.30 and […]
More Stories
Shoe Carnival, Inc. (SCVL) to Issue Quarterly Dividend of $0.14 on October 21st
Shoe Carnival, Inc. (NASDAQ:SCVL – Get Free Report) declared a quarterly dividend on Tuesday, September 17th, Zacks reports. Investors of...
Shoe Carnival, Inc. (SCVL) to Issue Quarterly Dividend of $0.14 on October 21st
Shoe Carnival, Inc. (NASDAQ:SCVL – Get Free Report) declared a quarterly dividend on Tuesday, September 17th, Zacks reports. Investors of...
UN chief strongly condemns Mali terrorist attack
UN Secretary-General António Guterres has called for accountability following a “despicable” terrorist attack in Mali this week, his Spokesperson said...
Whole generation of children ‘lost’ amid ongoing Gaza war, UNICEF warns
Last October’s terror attacks by Hamas and other Palestinian armed groups on Israeli communities marked a devastating day for children,...
Security Council: Middle East envoy warns against escalation, highlights continued Israeli settlement activity
The UN envoy supporting peace efforts between Israelis and Palestinians voiced grave concern over the growing risk of widescale regional...
Blackstone Inc. (NYSE:BX) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Blackstone Inc. (NYSE:BX – Get Free Report) have been given an average recommendation of “Hold” by the nineteen...